Smith & Nephew (SNN) Gross Profit Growth (3y) (2012 - 2024)
Smith & Nephew (SNN) Gross Profit Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.15% |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | 8.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.26% |
| Dec 31, 2023 | 10.97% |
| Dec 31, 2022 | -0.18% |
| Dec 31, 2021 | 0.11% |
| Dec 31, 2020 | -7.11% |
| Dec 31, 2019 | 2.70% |
| Dec 31, 2018 | 1.56% |
| Dec 31, 2017 | 1.36% |
| Dec 31, 2016 | 28.14% |
| Dec 31, 2015 | 29.42% |
| Dec 31, 2014 | -18.99% |
| Sep 30, 2014 | 25.99% |
| Mar 31, 2014 | 1,077,595.26% |
| Dec 31, 2013 | 2.94% |
| Mar 31, 2013 | 10,309.28% |
| Dec 31, 2012 | 10,652.85% |
| Jun 30, 2012 | 8,335.04% |
| Mar 31, 2012 | 1,009,395.60% |